의약품 관련 법령
Assessing the Irritation and Sensitization Potential of Transdermal and Topical Delivery Systems for ANDAs
| 작성자 | 관리자 | ||
|---|---|---|---|
| 작성일 | 2018-10-15 | 조회수 | 1,989 |
| 국가정보 | 북 아메리카>미국 | ||
| 출처 | FDA | ||
| 원문 | https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm064995.htm | ||
| 첨부파일 | |||
UCM622672.pdf(235.12KB)미국 FDA에서 발표한 Assessing the Irritation and Sensitization Potential of Transdermal and Topical Delivery Systems for ANDAs 입니다.
- 이전글 Presenting Quantitative Efficacy and Risk Information in Direct-to-Consumer Promotional Labeling and Advertisements
- 다음글 Assessing Adhesion with Transdermal Delivery Systems and Topical Patches for ANDAs Draft
